戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 risk of the emergence of treatment-resistant mutant virus.
2 but not CLDN1, were infectable only with the mutant virus.
3 nd the infectivity of a class II IN deletion mutant virus.
4 genetically engineered CTL epitope-deficient mutant virus.
5 ouse studies show extreme attenuation of the mutant virus.
6 ored replication and virulence of the dNSP16 mutant virus.
7  in RAL IC50 than that of the IN-G140S/Q148H mutant virus.
8 s recruited in the airways compared with the mutant virus.
9 ited higher infectivity than either parental mutant virus.
10 dly diminished in cells infected with EBNA3A mutant virus.
11  the acquisition of transmissibility by this mutant virus.
12 liver in comparison to those produced by the mutant virus.
13 lial cells following infection with the UL78 mutant virus.
14 ntly decreased following reactivation of the mutant virus.
15 genes) or after infection with the DeltaICP0 mutant virus.
16 tly delayed in cells infected with the pUL25 mutant virus.
17 HA) mRNA nuclear export was seen with an NS1 mutant virus.
18  RNA in virions of wild-type, but not escape mutant, virus.
19 y to evaluate the antigenic phenotype of the mutant viruses.
20 athology following intranasal infection with mutant viruses.
21 multiple mutations were less fit than single-mutant viruses.
22 teracting with the MAbs, we generated escape mutant viruses.
23 d in cells infected with wild-type and ORF12 mutant viruses.
24  from mice infected with wild-type or glycan mutant viruses.
25 nds, the attenuated VACV was replaced by the mutant viruses.
26 e characteristics were unchanged for the two mutant viruses.
27  study, confirmed potency and selectivity of mutant viruses.
28  a dominant-negative, deacetylase-dead point mutant virus (AAV-HDAC3(Y298H)-v5), we found that select
29 press the DUB mutant and showed that the DUB mutant virus activated an earlier type I interferon resp
30                                   Thus, this mutant virus adapted to the loss of CLDN1 by developing
31 reated or IFN-treated cells infected by this mutant virus (AdEasyE1Sub19) contained much higher stead
32  we engineered a recombinant KSHV ORF52-null mutant virus and found that loss of ORF52 results in red
33    Using reverse genetics, we engineered Ubl mutant viruses and found that AM2 (V787S) and AM3 (V785S
34 g rates of wild-type virus, fitness costs of mutant virus, and growth rates of both viruses.
35    Since wt virions could not complement the mutant viruses, and the mutant viruses did not effective
36 and most viral gene expression of the L4-33K mutant virus are comparable to those of the wild-type vi
37 e not required for effective host control of mutant virus as all N1347A virus-infected mice survived
38 ectron microscopy to reveal that the gH-null mutant virus assembled and exited from cells normally, c
39 eceptor homolog, with the infectivity of one mutant virus being >500-fold less with the quail TVA rec
40 ers was associated with the selection of the mutant virus both in humans and in vitro.
41 ffectively attenuated the resulting SARS-CoV mutant viruses both in vitro and in vivo.
42  of PACT compromised IFN-I activation by the mutant virus, but not wild-type virus, a finding consist
43 ile in IFN-deficient Vero cells, both WT and mutant viruses can replicate at relatively high levels.
44                                            A mutant virus carrying a truncation deletion of the C-ter
45 us in virus-specific antiserum gives rise to mutant viruses carrying mutations A125T+A151T+L217Q in t
46 re explained in part by the observation that mutant viruses carrying NNRTI plus INSTI resistance muta
47                          Characterization of mutant viruses carrying phenylalanine (Phe)-to-alanine (
48                                              Mutant viruses carrying substitutions at residue 145 sho
49 ated from lesions of animals inoculated with mutant virus contained mutations in the area of 3A that
50                                          The mutant viruses contained mutations in the hr1 region of
51                                          The mutant virus containing a substitution of Ala for Arg in
52                                        An LR mutant virus containing stop codons at the amino terminu
53 ing the latency-reactivation cycle because a mutant virus containing stop codons at the amino terminu
54 tal virus, SAT2/ZIM/7/83, indicated that the mutant virus containing the TQQS-to-ETPV mutation in the
55    In vitro susceptibility measurements with mutant viruses containing amino acid substitutions K70G,
56  infection of JCPyV by generating a panel of mutant viruses containing amino acid substitutions of th
57 ortant for these cellular processes and that mutant viruses containing mutations of CrPV-1A attenuate
58  in autophagic responses to wild-type or F17 mutant viruses could be detected, with autophagic activi
59 ication, as evidenced by the fact that their mutant viruses could not be rescued.
60 owth of a B1-deficient temperature-sensitive mutant virus (Cts2 virus) in U2OS osteosarcoma cells.
61 hree antibodies had neutralizing activity to mutant viruses deficient in gp41 carbohydrate attachment
62 ompare the phenotypes of an EBNA3A hypomorph mutant virus (Delta3A) and wild-type EBV.
63 of IFN-alpha/betaR-/- mice with the G50DblKo mutant virus demonstrated partial rescue of (i) acute vi
64  that recombinant E119D and E119A/D/G/-H274Y mutant viruses demonstrated reduced inhibition by all of
65 s; further, the recombinant T205-substituted mutant viruses described here would appear to be the fir
66              An infectious clone of one such mutant virus, designated rP11, appeared to be geneticall
67 nduced by infection with an E1B 19K deletion mutant virus did not repress macrophage proinflammatory
68 d not complement the mutant viruses, and the mutant viruses did not effectively inhibit wt gene expre
69 onotic potential; however, the wild-type and mutant viruses did not replicate to high titers in all i
70             Here we describe the creation of mutant viruses directly in the multicellular organism C.
71 ntly, compared with the wild-type virus, the mutant virus displayed a decreased capacity to infect an
72                           In addition, these mutant viruses displayed an infection defect in monkey c
73                           However, the drift mutant viruses displayed reduced stability, and we predi
74                                         This mutant virus does not require feces for stability at mos
75 re, we show that pro-necrotic murine CMV M45 mutant virus drives virus-induced necroptosis during non
76  the replication and pathogenesis of the DUB mutant virus (DUBmut) in cultured macrophages and in mic
77             We detected wild-type and single mutant viruses each possessing NA-F144C or NA-T342A in t
78                              Viral growth of mutant virus encoding K229R, mimicking a non-acetylated
79 everely impaired compared to wildtype or the mutant viruses encoding K77R or K113R.
80                    The HSV-1(F) gBDelta28syn mutant virus, encoding a carboxyl-terminal truncated gB,
81  TB reaction pharmacologically or by using a mutant virus enhanced or inhibited transmission, respect
82                                    In vitro, mutant viruses entered fibroblasts and epithelial cells
83 ere, we demonstrate that in U2OS cells, a B1 mutant virus escapes the block in DNA replication observ
84 its inoculated with either wtHTLV-2 or APH-2 mutant viruses established a persistent infection.
85                        When transmitted, the mutant virus eventually reverted to the wild type in 2 o
86                                           HR mutant viruses exhibit impairments at several stages of
87                                         This mutant virus exhibited a delayed disease in cattle compa
88              In vivo, the NLR nonbinding F1L mutant virus exhibited an attenuated phenotype similar t
89                                          The mutant virus exhibited drastically reduced expression of
90 rus-infected controls, animals infected with mutant virus exhibited higher viral load in cerebrospina
91   Correspondingly, the ORF64 DUB active site mutant virus exhibited impaired ability to establish lat
92                                          The mutant virus exhibited two functional alterations as com
93 wer-fidelity W237I (W237I(LF)) and W237L(LF) mutant viruses exhibited lower ribavirin resistance.
94                                        These mutant viruses exhibited normal capsid morphology but we
95 erved in other cell types and, instead, this mutant virus exhibits impaired late protein accumulation
96                                    The DC480 mutant virus expressed full-size UL37 as detected by the
97 ble to produce infectious virus in DCs, this mutant virus expresses early and late genes.
98                                            A mutant virus expressing NCp15 shows greatly reduced infe
99 s or in the livers of infected mice, whereas mutant viruses expressing inactive VP3-CTD (H718A or H79
100 l of vIL-6 variants and utilization of HHV-8 mutant viruses expressing selected variants in phenotypi
101     However, unlike the wild-type virus, the mutant virus failed to enter into the axoplasm of gangli
102                 Experimental infections with mutant viruses generated by using reverse genetics indic
103  mapping of the neutralizing mAbs via escape mutant virus generation revealed a shared binding epitop
104                                      Indeed, mutant virus genomes deficient for IE1 expression exhibi
105              In vaccinated animals, the GP85 mutant virus (GP85 DISC) induced an antibody response to
106     In both cell culture and mosquitoes, the mutant viruses grew equivalently and did not revert to w
107                                 The HA-K582I mutant virus had greater growth and virulence in DBA/2J
108             Patients infected with the H275Y mutant virus had higher day 28 mortality than others (80
109             Patients infected with the H275Y mutant virus had higher day-28 mortality than others (80
110 tinocytes infected with wild-type but not E7 mutant virus had perturbed transcriptional regulation of
111                                In vitro, the mutant virus had reduced binding and infectivity in chol
112   Likewise, the RT-E138K plus IN-G140S/Q148H mutant virus had significantly greater fold increases in
113                         Three of four escape mutant viruses had increased lethality in the DBA2/J mou
114 S/Q148H and the RT-E138K plus IN-G140S/Q148H mutant viruses had significantly greater fold increases
115            It reveals that the transmissible-mutant virus has a 200-fold preference for binding human
116 ximately 51-nucleotide contiguous subsegment mutant viruses having synonymous mutations revealed that
117                   Consequently, the ratio of mutant virus in feces is reduced following additional cy
118                                     The same mutant virus in mice also enhanced virus replication and
119 s improved the fitness of the IN-G140S/Q148H mutant virus in the presence of raltegravir (RAL); the R
120 support spread of progeny virus was an HAdV3 mutant virus in which formation of PtDd was disabled (mu
121 e than WT viruses in vivo Replication of P50-mutant viruses in an APOBEC3-expressing stable cell line
122  that prevent reproduction and spread of the mutant viruses in human cells.
123 hout infection with either wild-type or ICP0 mutant viruses in human embryonic lung cells (HEL) or HE
124 n of viral siRNAs and rapid clearance of the mutant viruses in mice.
125 assessed the stability of the 18 recombinant mutant viruses in regard to their growth kinetics, antig
126 the HA stalk can lead to expansion of escape mutant viruses in study participants challenged with a 2
127              Our work reveals a defect of HR mutant viruses in the formation of viral replication cen
128 n gene expression elicited by the native and mutant viruses in the lungs of infected mice were determ
129                  Co-culture of wild-type and mutant viruses in the presence of either a bNAb or human
130                Here, we constructed specific mutant viruses in which translation of D10 was prevented
131                                    Thus, the mutant virus incurs a fitness cost when environmental st
132                                        Point mutant viruses indicated that K90 is critical for the ne
133                   On the other hand, the two mutant viruses induced lower STAT1 phosphorylation and g
134                                       The LR mutant virus induces higher levels of apoptotic neurons
135                             However, E1B-55K mutant virus-infected cells became trapped in a mitotic-
136  the nucleus is severely compromised in UL92 mutant virus-infected cells, and mature virions are not
137 n the wild-type virus-infected cells and the mutant virus-infected cells.
138 reconstituted by plasmid transfection and in mutant virus-infected cells.
139          Immunofluorescence imaging of nsp15 mutant virus-infected macrophages revealed significant d
140 ages is dramatically increased during double-mutant virus infection and correlates with faster antivi
141 f UV treatment, lentivirus transduction, and mutant virus infection experiments, our results demonstr
142 ired to attenuate disease following PP1alpha-mutant virus infection.
143 e CTV, which correlated with invasion of the mutant virus into the immature xylem tracheid cells and
144 onstrate that the phenotype of an Ad5 L4-33K mutant virus is complex.
145                              Even though the mutant virus is heat resistant, it is susceptible to ina
146 mice with WT or AM2 virus and found that the mutant virus is highly attenuated, yet it replicates suf
147                                 Although the mutant virus is no longer able to propagate by extracell
148       Analysis of temperature-sensitive (ts) mutant viruses is a classic method allowing researchers
149  can partially complement a growth-defective mutant virus lacking both UL21a and UL97, with significa
150                                            A mutant virus lacking the mu2 ITAM activates NF-kappaB le
151 es similar to those in cells infected with a mutant virus lacking the UL37x1 gene, subUL37x1.
152  a novel approach that employs HCMV deletion mutant viruses lacking HLA class I immunoevasins and all
153                                              Mutant viruses lacking hydrolase activity were unable to
154  deletions in the CT, we were able to rescue mutant viruses lacking two or four residues (rDelta2 and
155 3 inhibitor, GSK872, and infection with this mutant virus led to phosphorylation and aggregation of M
156  restore infectivity to maturation-defective mutant viruses led us to hypothesize that SP may play an
157                                              Mutant viruses locked in either state remain competent t
158                    Additionally, most of the mutant viruses lost the capacity to escape MxA restricti
159                       Surprisingly, the A77V mutant virus maintained the ability to replicate in mono
160 dilated cardiomyopathy, suggesting that such mutant viruses may be the forms responsible for persiste
161 asmid (McKbac) and utilized to construct the mutant virus McK(gKDelta31-68), carrying a 37-amino-acid
162 viruses, we found that APOBEC3 restricts the mutant viruses more than WT viruses in vivo Replication
163                            Upon rescue of 21 mutant viruses, most substitutions in the receptor bindi
164 of mice with the macrodomain catalytic point mutant virus (N1347A) resulted in reductions in lethalit
165                                            A mutant virus, named Ban/AF, was developed in which the v
166 iii) that in cells infected with a DeltaICP0 mutant virus, Nectin-1 remained on the cell surface.
167 -KO Huh-7.5 cells supported infection by the mutant virus only when CLDN1, CLDN6, or CLDN9 was expres
168                                Purified PA-X mutant virus particles displayed an increased ratio of h
169      The defects in assembly of gE(-) US9(-) mutant virus particles were novel because they were neur
170                                  Late-domain mutant virus particles were seen at the uropod in form o
171                            In all cases, the mutant virus particles, as well as the antibody-bound wi
172                   In vivo, both WT and F1/F2 mutant viruses persistently infected mice, although F1,
173  C terminus of the V gene in PIV5 results in mutant viruses (PIV5DeltaSH and PIV5VDeltaC) that enhanc
174         However, in cells infected with this mutant virus, PML formed novel track-like structures tha
175                                            A mutant virus possessing both the NA-F144C and NA-T342A m
176 protect mice against lethal challenge of the mutant viruses, possibly owing to its ability to mediate
177 veolar lavage fluid after infection with the mutant virus PR8 A/NS1-Y89F (PR8 Y89F) when compared wit
178 ar clone JFH-1, thereby producing a range of mutant viruses predicted to possess altered RNA secondar
179                       Although the DeltaUS17 mutant virus produced numbers of infectious particles in
180                                        These mutant viruses produced smaller foci of infection in Ver
181                                   The L4-33K mutant virus produces only empty capsids, indicating a d
182 ing of this mutant confirmed the presence of mutant virus protein in the transfected BHK cell lysate.
183                  Of the 14 single and double mutant viruses recovered in the backbone of pH1N1, four
184 he -3 position was found to be important for mutant virus recovery.
185                                          The mutant viruses remained susceptible to favipiravir.
186                                          The mutant viruses replicate poorly in the brains of infecte
187                                          The mutant virus replicated similarly to the wild type in vi
188 npermissive for VACV; however, wild-type and mutant viruses replicated in triple-KO cells in which RN
189                        Although parental and mutant viruses replicated somewhat better in ducks than
190                            The efficiency of mutant virus replication was similar to that of wild-typ
191 verexpressing P50 in this cell line enhanced mutant virus replication.
192                           Infection with the mutant virus resulted in a significant decrease in viral
193 -resistant C57BL/6 mice with a CrmD deletion mutant virus resulted in uniform mortality due to excess
194                           Interestingly, the mutant virus retained partial PF74 binding, and its repl
195              Further characterization of the mutant viruses revealed differences in particle morpholo
196                   Analysis of revertant SL-1 mutant viruses revealed that a compensatory mutation in
197  isolate with a US17 deletion (the DeltaUS17 mutant virus) revealed blunted host innate and interfero
198  context of cells infected with wild-type or mutant virus, reversing the charge of these two residues
199 However, in the majority of the animals, the mutant virus reverted back to the wild-type sequence, he
200                        Strikingly, glyco-Gag mutant virus reverted to glyco-Gag-containing virus only
201 ately twice as many upregulated genes in the mutant virus samples by 48 h postinfection, despite iden
202 dicating that cells infected with a UL97-L1m mutant virus show no defects in growth or E2F-responsive
203 to the wild-type virus, the ToV-PLP knockout mutant virus showed impaired growth and induced higher e
204                                 Although the mutant virus showed slightly decreased replication in mi
205 restingly, in mice the neutralization escape mutant viruses showed either attenuation (Urbani backgro
206                                          All mutant viruses showed reduced sensitivity to sCD4 and CD
207     Upon infection of guinea pigs, the RNase mutant viruses stimulate strong IFN responses, fail to r
208    The recombinant A/Puerto Rico/8/34 (rPR8) mutant virus strain was attenuated and caused reduced mo
209 uation to generate W7-791, a live attenuated mutant virus strain.
210 , and RFC5 mRNAs also enhanced spread of the mutant virus, strengthening the biological significance
211 , amantadine and rimantadine, while the S31N mutant viruses, such as the pandemic 2009 H1N1 (H1N1pdm0
212 ters in the brains of mice infected with the mutant virus suggest that the alphavirus TF protein is i
213 a clinically relevant dolutegravir resistant mutant virus suggesting potential clinical benefits for
214 escued the virulence of the PP1alpha-binding mutant virus, suggesting an IFN-independent role for eIF
215 lls infected with a newly isolated UL32-null mutant virus, suggesting that UL32 acts as a chaperone c
216 le in cells infected with E1B-55K or E4-ORF6 mutant viruses, suggesting that Ad regulates paralog-spe
217 teraction did not affect the HA titer of the mutant viruses, suggesting that the same amount of viral
218                                          The mutant virus tended to predominate over the WT in mouse
219  of the wild-type virus with all the p24(CA) mutant viruses tested.
220                          We developed a FMDV mutant virus that could not bind DCTN3.
221 y as the wild-type virus; however, the smD1' mutant virus that does not express NS2 and NS4 underwent
222                       Importantly, the smA1' mutant virus that does not express NS3 and NS4 replicate
223 ine expressing A30.5, we isolated a deletion mutant virus that exhibits a defect in morphogenesis in
224 g its performance in samples infected with a mutant virus that fails to block transcription terminati
225                          Intriguingly, a TAg mutant virus that is unable to activate the DDR causes s
226             When exposed to CD11(+) DCs, the mutant virus that lacks the amino terminus of gamma134.5
227 ere, by using the previously described Q129H mutant virus that selectively lacks DNase activity but r
228       Although the G147R NA receptor-binding mutant virus that we characterize is a laboratory creati
229                                        Using mutant viruses that are defective for nuclear entry, we
230  become functionally exhausted or select for mutant viruses that escape T cell recognition.
231                   In addition, we found that mutant viruses that express an unstable form of the UL10
232 mutant, wild-type, and HA-H241Q and HA-K582I mutant viruses that have HA activation pH values of 6.3,
233                                   We created mutant viruses that incorporate most of the approximatel
234                           Growth analyses of mutant viruses that lack each individual miRNA revealed
235 h wild-type H18N11 leads to the emergence of mutant viruses that lack the N11 ectodomain and acquired
236  of action of these inhibitors, we generated mutant viruses that were resistant to the inhibitory eff
237 o AD-5 and neutralization activity toward gB mutant viruses that were similar to those of AD-5-specif
238                               However, DC480 mutant virus titers increased nearly 20-fold when the vi
239  increases neutralization sensitivity of the mutant virus to CD4 binding site (CD4bs)-directed antibo
240 We generated and characterized an Ad5 L4-33K mutant virus to further explore its function(s) during i
241 V reverse genetics, we generated a series of mutant viruses to define the contributions of macrodomai
242 dergo continual antigenic evolution allowing mutant viruses to evade host immunity acquired to previo
243 stigate the potential threat of serum escape mutant viruses to humans and poultry, the impact of thes
244  MDC-mediated capture and transmission of MA mutant viruses to T cells were decreased, suggesting tha
245 antly, we show that the macrodomain and PLP2 mutant viruses trigger production of type I interferon i
246 t of WT virus revealed that the destabilized mutant virus triggered the upregulation of more host gen
247            Here, we characterize a UL93 stop mutant virus (UL93st-TB40/E-BAC) to demonstrate that the
248        These findings may explain why ORF75c mutant viruses unable to degrade PML had no demonstrable
249      We observed that each individual escape mutant virus was able to avoid neutralization by its res
250  MHV68 G50DblKo virus demonstrated that this mutant virus was able to establish latency in the spleen
251 AR1-sufficient CON(kd) cells, only the C(ko) mutant virus was an effective inducer and the IFN-beta R
252                         A conditional lethal mutant virus was constructed by placing the A19 open rea
253                                          The mutant virus was debilitated in primary T cells and macr
254  DV1 was lethal, since no replication of the mutant virus was detected in human cells.
255                                When the UL92 mutant virus was evaluated, function was fully complemen
256 nce of EFV, the RT-E138K plus IN-G140S/Q148H mutant virus was fitter than one with the RT-E138K mutat
257 2J mice than the wild type did, although the mutant virus was highly attenuated in ducks.
258                                 The HA-Y231H mutant virus was highly susceptible to acid inactivation
259             Moreover, the replication of the mutant virus was markedly impaired in activated primary
260        The higher-fidelity W237F (W237F(HF)) mutant virus was more resistant to the mutagenic nucleos
261 ependent on the viral protein NSs, as an NSs mutant virus was not found to induce the equivalent sign
262                           Replication of the mutant virus was restored by pseudoreversion (A287V) or
263                                       An ns2 mutant virus was unable to replicate in the liver or ind
264 ingle-cycle (DISC) vaccine strategy, a GPCMV mutant virus was used that lacked the ability to express
265  at the membrane fusion step, and while this mutant virus was viable, it was significantly attenuated
266 n cytoplasmic virion envelopment, a cadre of mutant viruses was constructed and characterized.
267 istance mutations on the fitness of RT-Y181C mutant viruses was observed.
268 the replication of the S224A and S224A/T226A mutant viruses was reduced in cell culture and in vivo.
269 onoclonal antibody inhibition and a deletion mutant virus, we demonstrate that the KSHV virion glycop
270                     Using a miR-H2-deficient mutant virus, we found no evidence that miR-H2 represses
271                               By studying A6 mutant viruses, we found that A6 plays an essential role
272 verity and lethality caused by the different mutant viruses, we have identified specific residues loc
273 ncing of cyclophilin A (CypA), as well as CA mutant viruses, we implicated CypA in the SUN2-imposed b
274                               By engineering mutant viruses, we showed caspase cleavage at this site
275                                    Levels of mutant virus were dramatically reduced upon amplificatio
276 rse transcription reactions of the glyco-Gag mutant virus were substantially inhibited compared with
277 als, whereas the NA-T342A and NA-F144C/T342A mutant viruses were detected in the nasal turbinates, in
278 of the F proteins expressed by the recovered mutant viruses were efficiently cleaved and transported
279                                The resulting mutant viruses were evaluated in tissue culture and in m
280               While the UL15, UL32, and UL54 mutant viruses were fully susceptible to raltegravir, an
281               In the absence of drug, single-mutant viruses were less fit than the wild type; viruses
282 24)LL3D(YR) and double A(24)LL3B(PVKV)3D(YR) mutant viruses were markedly attenuated upon inoculation
283  although the fitness characteristics of the mutant viruses were not fully defined.
284 tly infected mice, although F1, F2 and F1/F2 mutant viruses were rapidly eliminated 1-7 days post-ino
285                         Both P480A and R482A mutant viruses were rescued, grew similarly to wild-type
286                                         Both mutant viruses were significantly less dependent on SR-B
287                               Instead, these mutant viruses were unable to expose VP2 upon arrival to
288 cine, based on a replication-defective HSV-2 mutant virus, which has been recently tested in clinical
289  address this question, we took advantage of mutant viruses whose viral entry into cells relies on th
290                                            A mutant virus with deletion of NS1 induced high levels of
291                                        An LR mutant virus with stop codons at the amino terminus of O
292                                        An LR mutant virus with stop codons at the amino terminus of t
293                                              Mutant viruses with increased frameshift efficiencies ha
294 cal for the induction of T-cell lymphomas as mutant viruses with precise deletions were significantly
295                         We demonstrated that mutant viruses with RBS deletions are able to escape pol
296 NY99 or Eg101 strain (NY-WT or EgCME-WT) and mutant viruses with substitutions of amino acid 159 of t
297             Competitive growth of the escape mutant viruses with the wild-type virus revealed that so
298  in the viral polymerase (L protein) of most mutant viruses, with the vast majority of the amino acid
299 e the wild-type virus, it can also bind to a mutant virus without inhibiting fusion or attachment.
300                      Surprisingly, ICP0-null mutant virus yields decreased upon TRIM27 depletion, arg

 
Page Top